Elanco Animal Health (ELAN) Tops Q1 EPS by 14c, Offers FY and Q2 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Elanco Animal Health Reports First Quarter 2021 Results
May 7, 2021 6:30 AM EDTExceeded first quarter 2021 guidance; Updating full year 2021 guidance, raising and tightening adjusted rangesÂ
Revenue in the first quarter was $1,242 million, comprised of $683 million from the legacy Elanco portfolio and $559 million from the legacy Bayer Animal Health portfolio. Gross margin was 54.2% on a reported basis and 59.2% on an adjusted basis, benefiting from the addition of the Bayer Animal Health portfolio as well as continued productivity improvements. Earnings per share (EPS) was $(0.12) (reported), or $0.37 (adjusted). Updating financial guidance for the full year 2021 with revenue... More